Ascites and Spontaneous Bacterial Peritonitis

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 1517-1541

  Runyon, Bruce A ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85124861051     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00091-3     Document Type: Chapter

References (185)

1. Akriviadis EA., Runyon BA The value of an algorithm in differentiating spontaneous from secondary bacterial peritonitis Gastroenterology 98 1990 127-133(Ref 28.)
2. Fernandez J., Navasa M., Garcia-Pagan JC., et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohumoral systems in patients with cirrhosis and spontaneous bacterial peritonitis J Hepatol 41 2004 384-390(Ref 82.)
3. Fernandez J., Navasa M., Planas R., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 2007 818-824(Ref 94.)
4. Fernandez J., Ruiz del Arbol L., Gomez C., et al. Norfloxacin vs. ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage Gastroenterology 131 2006 1049-1056(Ref 92.)
5. Follo A., Llovet JM., Navasa M., et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis Hepatology 20 1994 1495-1501(Ref 79.)
6. Perez-Ayuso RM., Arroyo V., Planas R., et al. Randomized comparative study of efficacy of furosemide vs. spironolactone in nonazotemic cirrhosis with ascites Gastroenterology 84 1983 961-968(Ref 116.)
7. Runyon BA Management of adult patients with ascites caused by cirrhosis Hepatology 39 2004 841-856(Ref 9.)
8. Runyon BA., Canawati HN., Akriviadis EA Optimization of ascitic fluid culture technique Gastroenterology 95 1988 1351-1355(Ref 23.)
9. Runyon BA., Hoefs JC., Morgan TR Ascitic fluid analysis in malignancy-related ascites Hepatology 8 1988 1104-1109(Ref 2.)
10. Runyon BA., McHutchison JG., Antillon MR., et al. Short-course vs. long-course antibiotic treatment of spontaneous bacterial peritonitis: A randomized controlled trial of 100 patients Gastroenterology 100 1991 1737-1742(Ref 87.)
11. Runyon BA., Montano AA., Akriviadis EA., et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites Ann Intern Med 117 1992 215-220(Ref 21.)
12. Runyon BA., Squier SU., Borzio M Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis J Hepatol 21 1994 792-796(Ref 61.)
13. Salerno F., Camma C., Enea M., et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis of individual patient data Gastroenterology 133 2007 825-834(Ref 156.)
14. Salerno F., Merli M., Riggio O., et al. Randomized controlled study of TIPS vs. paracentesis with albumin in cirrhosis with refractory ascites Hepatology 40 2004 629-635(Ref 151.)
15. Wong C., Holroyd-Leduc J., Thorpe KE., Straus SE Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 299 2008 1166-1178(Ref 145.)
16. Iwakiri Y., Groszmann RJ The hyperdynamic circulation of chronic liver disease: From the patient to the molecule Hepatology 43 2006 S121-S131.
17. Runyon BA., Hoefs JC., Morgan TR Ascitic fluid analysis in malignancy-related ascites Hepatology 8 1988 1104-1109.
18. Schrier RW Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy N Engl J Med 319 1988 1065-1072.
19. Hourigan LF., MacDonald GA., Purdie D., et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index Hepatology 29 1999 1215-1219.
20. Malekzadeh R., Mohamadnejad M., Rakhshani N., et al. Reversibility of cirrhosis in chronic hepatitis B Clin Gastroenterol Hepatol 2 2004 34-37.
21. Caldwell SH., Oelsner DH., Iezzoni JC., et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease Hepatology 29 1999 664-669.
22. Weinstein PJ., Noyer CM Rapid onset of massive ascites as the first presentation of systemic lupus erythematosus Am J Gastroenterol 95 2000 302-303.
23. Cattau El., Benjamin SB., Knuff TE., et al. The accuracy of the physical exam in the diagnosis of suspected ascites JAMA 247 1982 1164-1166.
24. Runyon BA Management of adult patients with ascites caused by cirrhosis Hepatology 39 2004 841-856.
25. Runyon BA Paracentesis of ascitic fluid: A safe procedure Arch Intern Med 146 1986 2259-2261.
26. Mannucci PM Abnormal hemostasis tests and bleeding in chronic liver disease: Are they related? No J Thromb Haemost 4 2006 721-723.
27. Grabau CM., Crago SF., Hoff LK., et al. Performance standards for therapeutic abdominal paracenteses Hepatology 40 2004 484-488.
28. Sakai H., Sheer TA., Mendler MH., Runyon BA Choosing the location for non-image guided abdominal paracentesis Liver Int 25 2005 984-986.
29. Runyon BA., Akriviadis EA., Keyser AJ The opacity of portal hypertension-related ascites correlates with the fluid’s triglyceride concentration Am J Clin Pathol 96 1991 142-143.
30. Rector WG Spontaneous chylous ascites of cirrhosis J Clin Gastroenterol 6 1984 369-372.
31. Runyon BA Ascitic fluid bilirubin concentration as a key to the diagnosis of choleperitoneum J Clin Gastroenterol 9 1987 543-545.
32. Hoefs JC Increase in ascites WBC and protein concentrations during diuresis in patients with chronic liver disease Hepatology 1 1981 249-254.
33. Runyon BA Strips and tubes: Improving the diagnosis of spontaneous bacterial peritonitis Hepatology 37 2003 745-747.
34. Nousbaum J-B., Cadranel J-F., Nahon P., et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis Hepatology 45 2007 1275-1281.
35. Runyon BA Approach to the patient with ascites In: Yamada T., Alpers D., Kaplowitz N., et al. Textbook of gastroenterology4th ed 2003 Lippincott Williams & Wilkins Philadelphia 948-972.
36. Runyon BA., Montano AA., Akriviadis EA., et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites Ann Intern Med 117 1992 215-220.
37. Hoefs JC Globulin correction of the albumin gradient: Correlation with measured serum to ascites colloid osmotic gradient Hepatology 16 1992 396-403.
38. Runyon BA., Canawati HN., Akriviadis EA Optimization of ascitic fluid culture technique Gastroenterology 95 1988 1351-1355.
39. Runyon BA., Antillon MR., Akriviadis EA., et al. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis J Clin Microbiol 8 1990 2811-2812.
40. Runyon BA., Hoefs JC Ascitic fluid analysis before, during, and after spontaneous bacterial peritonitis Hepatology 5 1985 257-259.
41. Runyon BA Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis Gastroenterology 91 1986 1343-1346.
42. Runyon BA Cardiac ascites: A characterization J Clin Gastroenterol 10 1988 410-412.
43. Akriviadis EA., Runyon BA The value of an algorithm in differentiating spontaneous from secondary bacterial peritonitis Gastroenterology 98 1990 127-133.
44. Runyon BA Amylase levels in ascitic fluid J Clin Gastroenterol 9 1987 172-174.
45. Haas LS., Gates LK Jr The ascites to serum amylase ratio identifies two distinct populations in acute pancreatitis with ascites Pancreatology 2 2002 100-103.
46. Hillebrand DJ., Runyon BA., Yasmineh WG., Rynders GP Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States Hepatology 24 1996 1408-1412.
47. Altamirano M., Kelly MT., Wong A., et al. Characterization of a DNA probe for detection of Mycobacterium tuberculosis complex in clinical samples by polymerase chain reaction J Clin Microbiol 30 1992 2173-2176.
48. Motherby H., Nadjari B., Friegel P., et al. Diagnostic accuracy of effusion cytology Diagn Cytopath 20 1999 350-357.
49. Chetty R., Learmonth GM., Taylor DA Giant cell hepatocellular carcinoma Cytopathology 1 1990 233-237.
50. Kielhorn E., Schofield K., Rimm DL Use of magnetic enrichment for detection of carcinoma cells in fluid specimens Cancer 94 2002 205-211.
51. Press OW., Press NO., Kaufman SD Evaluation and management of chylous ascites Ann Intern Med 96 1982 358-364.
52. Runyon BA., Antillon MR Ascitic fluid pH and lactate: Insensitive and nonspecific tests in detecting ascitic fluid infection Hepatology 13 1991 929-935.
53. Albillos A., Cuervas-Mons V., Millan I., et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis Gastroenterology 98 1990 134-140.
54. Runyon BA Elevated ascitic fluid fibronectin: A non-specific finding J Hepatol 3 1986 219-222.
55. Runyon BA Editorial: Malignancy-related ascites and ascitic fluid “humoral tests of malignancy.” J Clin Gastroenterol 18 1994 94-98.
56. Loewenstein MS., Rittgers RA., Feinerman AE., et al. CEA assay of ascites and detection of malignancy Ann Intern Med 88 1978 635-638.
57. Arora A., Seth S., Acharya SK., et al. Hepatic coma as a presenting feature of constrictive pericarditis Am J Gastroenterol 88 1993 430-432.
58. Sheer TA., Joo E., Runyon BA Usefulness of serum N-terminal-BNP in distinguishing ascites due to cirrhosis from ascites due to heart failure J Clin Gastroenterol 2009.
59. Saab S., Rickman LS., Lyche KD Ascites and the acquired immunodeficiency syndrome Medicine 89 1996 131-135.
60. Wong W-M., Wu P-C., Yuen M-F., et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection Hepatology 31 2000 201-206.
61. Weisman IM., Moreno AJ., Parker AL., et al. Gastrointestinal dissemination of coccidioidomycosis Am J Gastroenterol 81 1986 589-593.
62. Han S-HB., Reynolds TB., Fong T-L Nephrogenic ascites: Analysis of 16 cases and review of the literature Medicine 77 1998 233-244.
63. Ackerman Z Ascites in nephrotic syndrome: Incidence, patients’ characteristics and complications J Clin Gastroenterol 22 1996 31-34.
64. Mauer K., Manzione NC Usefulness of the serum-ascites albumin gradient in separating transudative from exudative ascites: Another look Dig Dis Sci 33 1988 1208-1212.
65. Brown MW., Burk RF Development of intractable ascites following upper abdominal surgery in patients with cirrhosis Am J Med 80 1986 879-883.
66. Ikeda Y., Kanematsu T., Matsumata T., et al. Liver resection and intractable postoperative ascites Hepatogastroenterology 40 1993 14-16.
67. Fabregues F., Balasch J., Gines P., et al. Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome Am J Gastroenterol 94 1999 994-999.
68. Case records of the Massachusetts General Hospital. Case 39-1992. A 49-year-old woman with peripheral neuropathy, hepatosplenomegaly, and intermittent abdominal pain N Engl J Med 327 1992 1014-1021.
69. de Kerguenec C., Hillaire S., Molinie V., et al. Hepatic manifestations of hemophagocytic syndrome: A study of 30 cases Am J Gastroenterol 96 2001 852-857.
70. Cirera I., Navasa M., Rimola A., et al. Ascites after liver transplantation Liver Transpl 6 2000 157-162.
71. Stewart C., Wertheim J., Olthoff K., et al. Ascites after liver transplantation-a mystery Liver Transpl 10 2004 654-660.
72. Correia JP., Conn HO Spontaneous bacterial peritonitis in cirrhosis: Endemic or epidemic? Med Clin North Am 59 1975 963-981.
73. Runyon BA Monomicrobial non-neutrocytic bacterascites: A variant of spontaneous bacterial peritonitis Hepatology 12 1990 710-715.
74. Runyon BA., Hoefs JC Culture-negative neutrocytic ascites: A variant of spontaneous bacterial peritonitis Hepatology 4 1984 1209-1211.
75. Runyon BA., Canawati HN., Hoefs JC Polymicrobial bacterascites: A unique entity in the spectrum of infected ascitic fluid Arch Intern Med 146 1986 2173-2175.
76. Runyon BA., Squier SU., Borzio M Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis J Hepatol 21 1994 792-796.
77. Guarner C., Runyon BA., Young S., et al. Intestinal bacterial overgrowth and bacterial translocation in an experimental model of cirrhosis in rats J Hepatol 26 1997 1372-1378.
78. Runyon BA., Morrissey R., Hoefs JC., et al. Opsonic activity of human ascitic fluid: A potentially important protective mechanism against spontaneous bacterial peritonitis Hepatology 5 1985 634-637.
79. Runyon BA Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis Hepatology 8 1988 632-635.
80. Runyon BA., Sugano S., Kanel G., et al. A rodent model of cirrhosis and spontaneous bacterial peritonitis Gastroenterology 100 1991 489-493.
81. Such J., Frances R., Munoz C., et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-nonneutrocytic ascites Hepatology 36 2002 135-141.
82. Dunn DL., Barke RA., Ewald DC., Simmons RL Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity Arch Surg 122 1987 105-110.
83. McHutchison JG., Runyon BA Spontaneous bacterial peritonitis In: Surawicz CM., Owen RL Gastrointestinal and hepatic infections 1994 WB Saunders Philadelphia 455-475.
84. Fernandez J., Navasa M., Gomez J., et al. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 2002 140-148.
85. Borzio M., Salerno F., Piantoni L., et al. Bacterial infection in patients with advanced cirrhosis: A multicentre prospective study Dig Liver Dis 33 2001 41-48.
86. Bernard B., Cadranel J-F., Valla D., et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study Gastroenterology 108 1995 1828-1834.
87. Cadranel J-P., Denis J., Pauwels A., et al. Prevalence and risk factors of bacteriuria in cirrhotic patients: A prospective case-control multicenter study in 244 patients J Hepatol 31 1999 464-468.
88. Rimola A., Garcia-Tsao G., Navasa M., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document J Hepatol 32 2000 142-153.
89. Papadakis MA., Arieff AI Unpredictability of clinical evaluation of renal function in cirrhosis: Prospective study Am J Med 82 1987 945-952.
90. Hampel H., Bynum GD., Zamora E., et al. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis Am J Gastroenterol 96 2001 2206-2210.
91. Felisart J., Rimola A., Arroyo V., et al. Cefotaxime is more effective than ampicillin-tobramycin in cirrhotics with severe infections Hepatology 5 1985 457-462.
92. Runyon BA., Akriviadis EA., Sattler FR., et al. Ascitic fluid and serum cefotaxime and desacetylcefotaxime levels in patients treated for bacterial peritonitis Dig Dis Sci 36 1991 1782-1786.
93. Ricart E., Soriano G., Novella MT., et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients J Hepatol 32 2000 596-602.
94. Follo A., Llovet JM., Navasa M., et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis Hepatology 20 1994 1495-1501.
95. Such J., Hillebrand DJ., Guarner C., et al. Nitric oxide in ascitic fluid is an independent predictor of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis Eur J Gastroenterol Hepatol 16 2004 1-7.
96. Sort P., Navasa M., Arroyo V., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403-409.
97. Fernandez J., Navasa M., Garcia-Pagan JC., et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohumoral systems in patients with cirrhosis and spontaneous bacterial peritonitis J Hepatol 41 2004 384-390.
98. Runyon BA Albumin infusion for spontaneous bacterial peritonitis Lancet 354 1999 1838-1839.
99. Navasa M., Follo A., Llovet JM., et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis Gastroenterology 111 1996 1011-1017.
100. Terg R., Cobas S., Fassio E., et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: Results of a multicenter, randomized study J Hepatol 33 2000 564-569.
101. Aparicio JR., Such J., Pascual S., et al. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: Clinical consequences J Hepatol 31 1999 277-283.
102. Runyon BA., McHutchison JG., Antillon MR., et al. Short-course vs. long-course antibiotic treatment of spontaneous bacterial peritonitis: A randomized controlled trial of 100 patients Gastroenterology 100 1991 1737-1742.
103. Soriano G., Teixedo M., Guarner C., et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis Gastroenterology 100 1991 477-481.
104. Gines P., Rimola A., Planas R., et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial Hepatology 12 1990 716-724.
105. Soriano G., Guarner C., Tomas A., et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage Gastroenterology 103 1992 1267-1272.
106. Younossi Z., McHutchison JG., Ganiats TG An economic analysis of norfloxacin against spontaneous bacterial peritonitis J Hepatol 27 1997 295-298.
107. Fernandez J., Ruiz del Arbol L., Gomez C., et al. Norfloxacin vs. ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage Gastroenterology 131 2006 1049-1056.
108. Runyon BA., Borzio M., Young S., et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis Hepatology 21 1995 1719-1724.
109. Fernandez J., Navasa M., Planas R., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 2007 818-824.
110. Terg R., Fassio E., Guevara M., et al. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study J Hepatol 48 2008 774-779.
111. Runyon BA A pill a day can improve survival in patients with advanced cirrhosis Gastroenterology 133 2007 1029-1031.
112. Guarner C., Runyon BA., Heck M., et al. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis and survival in cirrhotic rats Dig Dis Sci 44 1999 1957-1962.
113. Singh N., Gayowski T., Yu VL., et al. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized trial Ann Intern Med 122 1995 595-598.
114. Rolando N., Gimson A., Philpott-Howard J., et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: Role of antibiotic prophylaxis J Hepatol 18 1993 290-294.
115. Goulis J., Armonis A., Patch D., et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage Hepatology 27 1998 1207-1212.
116. Rongey CA., Lim NH., Runyon BA Cellulitis in patients with cirrhosis and edema: An under-recognized complication currently more common than spontaneous bacterial peritonitis Open Gastroenterol J 2 2008 24-27.
117. Titó L., Ginès P., Arroyo V., et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites Gastroenterology 98 1990 146-151.
118. Strauss RM., Boyer TD Hepatic hydrothorax Semin Liver Dis 17 1997 227-232.
119. Xiol X., Castellote J., Baliellas C., et al. Spontaneous bacterial empyema in cirrhotic patients: Analysis of eleven cases Hepatology 11 1990 365-370.
120. Runyon BA., Greenblatt M., Ming RHC Hepatic hydrothorax is a relative contraindication to chest tube insertion Am J Gastroenterol 81 1986 566-567.
121. Temes RT., Dacis MS., Follis FM., et al. Videothorascopic treatment of hepatic hydrothorax Ann Thorac Surg 64 1997 1468-1469.
122. Fagan SP., Awad SS., Berger DH Management of complicated umbilical hernias in patients with end-stage liver disease and refractory ascites Surgery 135 2004 679-682.
123. Runyon BA., Juler GL Natural history of umbilical hernias in patients with and without ascites Am J Gastroenterol 80 1985 38-39.
124. Sarit C., Eliezer A., Mizrahi S Minimally invasive repair of recurrent strangulated umbilical hernia in cirrhotic patient with refractory ascites Liver Transpl 9 2003 621-622.
125. Bajaj JS., Varma RR TIPS as therapeutic modality for umbilical hernia in patients with advanced liver disease Liver Transpl 10 2004 159-160.
126. Oktedalen O., Nygaard K., Osnes M Somatostatin in the treatment of pancreatic ascites Gastroenterology 99 1990 1520-1521.
127. Angeli P., Wong F., Watson H., et al. Hyponatremia in cirrhosis: Results of a patient population survey Hepatology 44 2006 1535-1542.
128. Runyon BA Historical aspects of treatment of patients with cirrhosis and ascites Semin Liver Dis 17 1997 163-173.
129. Eisenmenger WJ., Blondheim SH., Bongiovanni AM., et al. Electrolyte studies on patients with cirrhosis of the liver J Clin Invest 29 1950 1491-1499.
130. Stiehm AJ., Mendler MH., Runyon BA Detection of diuretic-resistance or diuretic-sensitivity by the spot urine Na/K ratio in 729 specimens from cirrhotics with ascites: Approximately 90% accuracy as compared to 24-hour urine Na excretion [abstract] Hepatology 36 2002 222A.
131. Perez-Ayuso RM., Arroyo V., Planas R., et al. Randomized comparative study of efficacy of furosemide vs. spironolactone in nonazotemic cirrhosis with ascites Gastroenterology 84 1983 961-968.
132. Sungaila I., Bartle WR., Walker SE., et al. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites Gastroenterology 102 1992 1680-1685.
133. Cohn JN The management of chronic heart failure N Engl J Med 335 1996 490-498.
134. Angeli P, Fasolato S, Mazza E, et al. Combined versus sequential diuretic treatment of moderate ascites in nonazotemic patients with cirrhosis. Gut 2009 [Epub ahead of print].
135. Stanley MM., Ochi S., Lee KK., et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites N Engl J Med 321 1989 1632-1638.
136. Daskalopoulos G., Laffi G., Morgan T., et al. Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites Gastroenterology 2 1987 1859-1863.
137. Chalasani N., Gorski JC., Horlander JC., et al. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients J Am Soc Nephrol 12 2001 1010-1016.
138. Pockros PJ., Reynolds TB Rapid diuresis in patients with ascites from chronic liver disease: The importance of peripheral edema Gastroenterology 90 1986 1827-1833.
139. Mirouze D., Zipser RD., Reynolds TB Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis Hepatology 3 1983 50-55.
140. Runyon BA., Antillon MR., Montano AA Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement Gastroenterology 97 1989 158-162.
141. Wong F., Blei AT., Blendis LM., et al. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo-controlled trial Hepatology 3 2003 182-191.
142. Arroyo V., Gines P., Gerbes AL., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Heptology 23 1996 164-176.
143. Planas R., Montoliu S., Balleste B., et al. Natural history of patients hospitalized for management of cirrhotic ascites Clin Gastroenterol Hepatol 4 2006 1385-1394.
144. Stanley MM., Reyes CV., Greenlee HB., et al. Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites Dig Dis Sci 41 1996 571-577.
145. Gines P., Arroyo V., Quintero E., et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: Results of a randomized study Gastroenterology 93 1987 234-241.
146. Smith GS., Barnard GF Massive volume paracentesis (up to 41 liters) for the outpatient management of ascites J Clin Gastroenterol 25 1997 402-403.
147. Gines P., Tito L., Arroyo V., et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 1988 1493-1502.
148. Gines A., Fernandez-Esparrach G., Monescillo A., et al. Randomized trial comparing albumin, dextran 70 and polygeline in cirrhotic patients with ascites treated by paracentesis Hepatology 111 1996 1002-1010.
149. Ruiz-del-Arbol L., Monescillo A., Jimenez W., et al. Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis Gastroenterology 113 1997 579-586.
150. Rothschild M., Oratz M., Evans C., et al. Alterations in albumin metabolism after serum and albumin infusions J Clin Invest 43 1964 1874-1880.
151. Wilkinson P., Sherlock S The effect of repeated albumin infusions in patients with cirrhosis Lancet 2 1962 1125-1129.
152. Pietrangelo A., Panduro A., Chowdhury JR., et al. Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat J Clin Invest 89 1992 1755-1760.
153. Runyon BA Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume Am J Gastroenterol 92 1996 371-373.
154. Peltekian KM., Wong F., Liu PP., et al. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites Am J Gastroenterol 92 1997 394-399.
155. Moller S., Bendtsen F., Henriksen JH Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis Gastroenterology 109 1995 1917-1925.
156. Planas R., Gines P., Arroyo V., et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis Gastroenterology 99 1990 1736-1744.
157. Christidis C., Mal F., Ramos J., et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethyl starch infusions J Hepatol 35 2001 726-732.
158. Vermeulen LC., Ratko TA., Erstad BL., et al. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloids, and crystalloid solutions Arch Intern Med 155 1995 373-379.
159. The SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 350 2004 2247-2256.
160. Wong C., Holroyd-Leduc J., Thorpe KE., Straus SE Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 299 2008 1166-1178.
161. Singh V., Kumar R., Nain CK., et al. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosos: A randomized trial J Gastroenterol Hepatol 21 2006 303-307.
162. Ochs A., Rossle M., Haag K., et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites N Engl J Med 332 1995 1192-1197.
163. Rossle M., Ochs A., Gulberg V., et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites N Engl J Med 342 2000 1701-1707.
164. Gines P., Uriz J., Calahorra B., et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis Gastroenterology 123 2002 1839-1847.
165. Sanyal AJ., Genning C., Reddy KR., et al. The North American Study for the Treatment of Refractory Ascites Gastroenterology 123 2003 634-641.
166. Salerno F., Merli M., Riggio O., et al. Randomized controlled study of TIPS vs. paracentesis with albumin in cirrhosis with refractory ascites Hepatology 40 2004 629-635.
167. Saab S, Niets JM, Ly D, et al. TIPS versus paracentesis for patients with refractory ascites may benefit from trans-jugular intrahepatic portosystemic stent-shunts. Cochrane Database Syst Rev 2004; 3:CD004889.
168. D’Amico G., Luca A., Morabito A., et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: A meta analysis Gastroenterology 129 2005 1282-1293.
169. Albillos A., Banares R., Gonzalez M., et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites J Hepatol 43 2005 990-996.
170. Mathurin DP., Moreau DS., Moreau R., et al. Transjugular intrahepatic portosystemic shunt in refractory ascites: A meta-analysis Liver Int 25 2005 349-356.
171. Salerno F., Camma C., Enea M., et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis of individual patient data Gastroenterology 133 2007 825-834.
172. Angermayr B., Cejna M., Koenig F., et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents Hepatology 38 2003 1043-1050.
173. Bureau C., Garcia-Pagan JC., Otal P., et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: Results of a randomized study Gastroenterology 126 2004 469-475.
174. Petersen B Intravascular ultrasound-guided direct intrahepatic portacaval shunt: Description of technique and technical refinements J Vasc Interv Radiol 14 2003 21-32.
175. Rosemurgy AS., Zervos EE., Clark WC., et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: A prospective randomized trial Ann Surg 239 2004 883-891.
176. Trotter J., Pieramici E., Everson GT Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS) Dig Dis Sci 50 2005 1356-1360.
177. Romanelli RG., La Villa G., Barletta G., et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblended randomized trial World J Gastroenterol 12 2006 1403-1407.
178. McGill RL., Bakos JR., Marcus RJ Ascites reinfusion dialysis (ARD) for renal failure with refractory ascites Clin Nephrol 62 2004 374-379.
179. Davenport A Ultrafiltration in diuretic-resistant volume overload in nephrotic syndrome and patients with ascites due to chronic liver disease Cardiology 96 2001 190-195.
180. Krag A., Moller S., Henriksen JH., et al. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome Hepatology 46 2007 1863-1871.
181. Koconis KG., Singh H., Soares G Partial splenic embolization in the treatment of patients with portal hypertension: A review of the English language literature J Vasc Internvent Radiol 18 2007 463-481.
182. Rozenblit GN., Del Guercio LRM., Rundback JH., et al. Peritoneal-urinary drainage for treatment of refractory ascites: A pilot study J Vasc Interv Radiol 9 1998 998-1005.
183. Park JS., Won JY., Park SI., et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites J Vasc Interv Radiol 12 2001 1445-1448.
184. Gines P., Quintero E., Arroyo V., et al. Compensated cirrhosis: Natural history and prognostic factors Hepatology 7 1987 12-18.
185. D’Amico G., Morabito A., Pagliaro L., Marubini E Survival and prognostic indicators in compensated and decompensated cirrhosis Dig Dis Sci 31 1986 468-475.